Suppr超能文献

在使用奥滨尤妥珠单抗联合苯达莫司汀治疗滤泡性淋巴瘤后,巨细胞病毒感染引发的原发性肾上腺功能不全

Primary Adrenal Insufficiency Triggered by Cytomegalovirus Infection after Obinutuzumab Plus Bendamustine Therapy for Follicular Lymphoma.

作者信息

Nakamura Takashi, Uryu Hideki, Kawashima Ryutaro, Ishiguro Mizuki, Tanizawa Mika, Kanazawa Yasushi, Yamazaki Hiroyuki, Yahagi Yuichi

机构信息

Department of Hematology, Kawaguchi Municipal Medical Center, Japan.

Department of Endocrinology and Diabetes, Kawaguchi Municipal Medical Center, Japan.

出版信息

Intern Med. 2025 Jan 15;64(2):273-279. doi: 10.2169/internalmedicine.3334-23. Epub 2024 May 30.

Abstract

A 69-year-old man was diagnosed with follicular lymphoma (grade 3A). Obinutuzumab combined with bendamustine (OB) therapy was initiated as salvage chemotherapy. Nausea, abdominal pain, and hyponatremia appeared after six courses of OB therapy; cytomegalovirus (CMV) enteritis with primary adrenal insufficiency (PAI) was a complication. Ganciclovir and hydrocortisone were administered, and the clinical findings improved. PAI caused by CMV infection has mainly been reported in patients with acquired immunodeficiency syndrome. In the present case, the PAI triggered by CMV infection led to immunodeficiency after chemotherapy.

摘要

一名69岁男性被诊断为滤泡性淋巴瘤(3A级)。开始使用奥滨尤妥珠单抗联合苯达莫司汀(OB)疗法进行挽救性化疗。在进行六个疗程的OB治疗后出现恶心、腹痛和低钠血症;巨细胞病毒(CMV)肠炎伴原发性肾上腺功能不全(PAI)是一种并发症。给予更昔洛韦和氢化可的松治疗后,临床症状有所改善。CMV感染引起的PAI主要在获得性免疫缺陷综合征患者中报道。在本病例中,CMV感染引发的PAI导致化疗后免疫缺陷。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad40/11802235/a927ddcdc7c2/1349-7235-64-0273-g001.jpg

相似文献

1
Primary Adrenal Insufficiency Triggered by Cytomegalovirus Infection after Obinutuzumab Plus Bendamustine Therapy for Follicular Lymphoma.
Intern Med. 2025 Jan 15;64(2):273-279. doi: 10.2169/internalmedicine.3334-23. Epub 2024 May 30.
3
Safety and efficacy of obinutuzumab with CHOP or bendamustine in previously untreated follicular lymphoma.
Haematologica. 2017 Apr;102(4):765-772. doi: 10.3324/haematol.2016.152272. Epub 2016 Dec 23.
8
Prolonged COVID-19 in an Immunocompromised Patient Treated with Obinutuzumab and Bendamustine for Follicular Lymphoma.
Intern Med. 2022 Aug 15;61(16):2523-2526. doi: 10.2169/internalmedicine.9136-21. Epub 2022 May 31.

本文引用的文献

2
Clinical entity of cytomegalovirus disease in patients with malignant lymphoma on bendamustine therapy: a single-institution experience.
Leuk Lymphoma. 2023 Jan;64(1):171-177. doi: 10.1080/10428194.2022.2131426. Epub 2022 Oct 12.
3
Real-world evidence of cytomegalovirus reactivation in non-Hodgkin lymphomas treated with bendamustine-containing regimens.
Open Med (Wars). 2021 Apr 21;16(1):672-682. doi: 10.1515/med-2021-0274. eCollection 2021.
4
Acute lymphoblastic leukemia complicating with adrenal insufficiency due cytomegalovirus infection.
Hematol Transfus Cell Ther. 2022 Jul-Sep;44(3):447-449. doi: 10.1016/j.htct.2021.01.008. Epub 2021 Mar 9.
6
CMV-associated adrenal insufficiency in a renal transplant recipient.
IDCases. 2017 Dec 26;11:44-45. doi: 10.1016/j.idcr.2017.12.009. eCollection 2018.
7
Cytomegalovirus.
Microbiol Spectr. 2016 Aug;4(4). doi: 10.1128/microbiolspec.DMIH2-0022-2015.
10
Cytomegalovirus-induced adrenal insufficiency in a renal transplant recipient.
Transplant Proc. 2009 Sep;41(7):2915-6. doi: 10.1016/j.transproceed.2009.07.024.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验